Gut bacteria play role in CAR-T cancer therapy

CAR-T cell therapy has been shown to be highly effective in treating some cancers. However, responses to this relatively new form of immunotherapy can vary, making it difficult for patients and doctors to predict cancer outcomes. Scientists have been puzzled by the range of responses. Now a new study by the German Cancer Research Centre (KDFZ), in collaboration with researchers […]

Researchers find treatment options for patients whose blood cancer relapses after CAR-T

Mount Sinai and Memorial Sloan Kettering Cancer Center (MSK) researchers have identified therapies that can help patients with the blood cancer multiple myeloma who try an immunotherapy known as CAR-T only to find their cancer coming back afterwards. CAR-T, short for chimeric antigen receptor T-cell therapy, enlists immune cells called T cells to fight multiple myeloma by altering them in […]